About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Nanoparticle Created by UT Arlington Physicist for Cancer Therapy

by Himabindu Venkatakrishnan on April 17, 2014 at 1:59 PM
 New Nanoparticle Created by UT Arlington Physicist for Cancer Therapy

A luminescent nanoparticle is being created by a physicist from University of Texas at Arlington, to use in security-related radiation detection, could be an advance in photodynamic cancer therapy.

Wei Chen, professor of physics and co-director of UT Arlington's Center for Security Advances Via Applied Nanotechnology, was testing a copper-cysteamine complex created in his lab when he discovered unexplained decreases in its luminescence, or light emitting power, over a time-lapse exposure to X-rays. Looking further, he found that the nanoparticles, called Cu-Cy, were losing energy as they emitted singlet oxygen - a toxic byproduct that is used to damage cancer cells in photodynamic therapy. Because Chen also is leading federally funded cancer research, he knew he had found something unique.

Advertisement

Testing revealed that the Cu-Cy nanoparticles, combined with X-ray exposure, significantly slowed tumor growth in lab studies. "This new idea is simpler and better than previous photodynamic therapy methods. You don't need as many steps. This material alone can do the job," Chen said. "It is the most promising thing we have found in these cancer studies and we've been looking at this for a long time." Chen's research is being published in the August edition of the Journal of Biomedical Nanotechnology under the title "A New X-Ray Activated Nanoparticle Photosensitizer for Cancer Treatment." Co-authors are Lun Ma, a research assistant professor, and Xiaoju Zou, a research associate.

The paper is available online at www.aspbs.com. The University has also filed a provisional patent application on the new complex. Photodynamic therapy, or PDT, harms cancer cells when a photosensitizer introduced into tumor tissue produces toxic
Advertisement
singlet oxygen after being exposed to light. In some studies, this light exposure is done through use of visible or near-infrared lasers. Others have found more success by also introducing luminescent nanoparticles into the tumor. Researchers activate the luminescent nanoparticle with near-infrared light or X-rays, which in turn activates the photosensitizer. Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Cancer News

Personalized Vaccine and T Cell Therapy for Ovarian Cancer Patients
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Kinase-Targeted Therapy Revolutionizes Colorectal Cancer Care
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
Novel Photo-Oxidation Therapy Holds Promise for Anticancer Treatment
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 Genes Linked to Aggressive Prostate Cancer
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Link Between Poor Oral Health and Head & Neck Cancer Survival Uncovered
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

New Nanoparticle Created by UT Arlington Physicist for Cancer Therapy Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests